<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107490">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01789463</url>
  </required_header>
  <id_info>
    <org_study_id>2010/03</org_study_id>
    <nct_id>NCT01789463</nct_id>
  </id_info>
  <brief_title>Physiotherapy and Capsulitis</brief_title>
  <official_title>Physiotherapy Versus Self Rehabilitation After Shoulder Dilatation for Primary Idiopathic Capsulitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Direction Générale de la Santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter randomised study, on parallel groups to compare recovery of functional amplitude
      following shoulder dilatation with auto rehabilitation in one group and physiotherapy in the
      other group.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Function of the shoulder joint (Score de Constant)</measure>
    <time_frame>12 months post shoulder dilatation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Visual Analogue Scale (at evening, rest, and at movement)</measure>
    <time_frame>12 months post shoulder dilatation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Arthritis</condition>
  <arm_group>
    <arm_group_label>Self rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Self rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Self rehabilitation plus physiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Self rehabilitation plus physiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Self rehabilitation</intervention_name>
    <arm_group_label>Self rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Self rehabilitation plus physiotherapy</intervention_name>
    <arm_group_label>Self rehabilitation plus physiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary idiopathic phase 2 capsulitis

          -  Diagnosis of capsulitis confirmed by shoulder dilatation

          -  Patients between 18 and 70 years of age

          -  Exclusion Criteria:

          -  Secondary capsulitis

          -  Shoulder pain of other etiology

          -  Cognitive disorders

          -  Patients less than 18 years, and more than 70 years of age
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard BOISAUBERT, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital FOCH  40, rue Worth 92150 Suresnes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Louis FRANCESCHI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IMM - 42, boulevard Jourdan 75014 Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital FOCH</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>February 11, 2013</lastchanged_date>
  <firstreceived_date>January 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
